MicroRNA‐383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2

Chaoyong Tu(Wenzhou Medical University), Weilin Wang(Zhejiang University)
Journal of Cellular and Molecular Medicine
February 23, 2019
Cited by 32


Related Papers